Endocrinology, Diabetes and Metabolism, University Hospital Basel and University of Basel, Petersgraben 4, CH-4031, Basel, Switzerland,
Diabetologia. 2014 Apr;57(4):653-5. doi: 10.1007/s00125-013-3153-0. Epub 2014 Jan 4.
Despite tremendous research efforts, type 1 diabetes is one of the few remaining autoimmune diseases without any approved immunological treatment. This observation compels us to reconsider the role of autoimmunity in the pathogenesis of this disease. In this commentary, we will review solely human data in an attempt to appreciate, in an unbiased manner, the importance and relevance of the immunological alterations in patients with type 1 diabetes. The aim of this paper is to generate reflection on this topic, rather than a controversy.
尽管研究工作取得了巨大进展,但 1 型糖尿病仍是少数几种尚无获批免疫治疗的自身免疫性疾病之一。这一观察结果促使我们重新审视自身免疫在该疾病发病机制中的作用。在本述评中,我们仅回顾人类数据,旨在以无偏倚的方式了解 1 型糖尿病患者免疫改变的重要性和相关性。本文的目的是引发对此问题的思考,而不是引发争议。